The CCLE API is a valuable resource in the drug development process. By providing access to drug sensitivity data, researchers can identify cancer cell lines that are responsive or resistant to particular drugs. This information can be used to design more effective drug trials and develop personalized treatment plans. Additionally, the API's genomic data can help identify potential biomarkers for drug response, leading to the development of targeted therapies.
